Scarica l'app Stockscreener
35.21
0.93%
-0.33
Precedente Chiudi:
$35.54
Aprire:
$35.54
Volume 24 ore:
22.62M
Relative Volume:
8.90
Capitalizzazione di mercato:
$4.40B
Reddito:
$1.12B
Utile/perdita netta:
$5.00M
Rapporto P/E:
3,521.00
EPS:
0.01
Flusso di cassa netto:
$-383.00M
1 W Prestazione:
-0.98%
1M Prestazione:
+8.01%
6M Prestazione:
+153.31%
1 anno Prestazione:
+205.11%
Intervallo 1D:
$35.02
$36.02
Intervallo di 1 settimana:
$34.91
$36.18
Portata 52W:
$7.62
$38.00
Indivior Plc Stock (INDV) Company Profile
Nome
Indivior Plc
Settore
Telefono
804-379-1090
Indirizzo
234 BATH ROAD, SLOUGH, BERKSHIRE
Confronta INDV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
35.21 | 4.44B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
122.24 | 54.10B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.90 | 46.85B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.90 | 43.82B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.35 | 34.79B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
517.13 | 21.83B | 3.08B | 1.24B | 1.07B | 25.61 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-06 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-22 | Ripresa | Jefferies | Buy |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-07-23 | Iniziato | Piper Sandler | Overweight |
| 2024-04-03 | Iniziato | Craig Hallum | Buy |
| 2023-07-13 | Iniziato | Northland Capital | Outperform |
Mostra tutto
Indivior Plc Borsa (INDV) Ultime notizie
Why hedge funds are buying Indivior PLC stock2025 Key Highlights & High Win Rate Trade Alerts - DonanımHaber
Indivior approves executive salary increases for senior leadership - TipRanks
Indivior Shareholders Approve Scheme of Arrangement - TipRanks
The Bull Case For Indivior (INDV) Could Change Following New SUBLOCADE Fentanyl-User Efficacy Data - simplywall.st
Extended-release buprenorphine shows efficacy in opioid use disorder By Investing.com - Investing.com Nigeria
Indivior (INDV) Trial Shows Potential of SUBLOCADE in Reducing O - GuruFocus
Extended-release buprenorphine shows efficacy in opioid use disorder - Investing.com
Monthly shot rapidly cuts opioid use in people using fentanyl heavily - Stock Titan
Indivior’s INDV-2000 Study Completion: A Potential Game-Changer for Opioid Use Disorder - TipRanks
Indivior (INDV) Is Up 8.9% After Newtyn Ups Stake And EBITDA Guidance RisesHas The Bull Case Changed? - Sahm
Indivior stock hits all-time high at 37.72 USD By Investing.com - Investing.com Canada
What drives Indivior PLC stock priceWeekly Market Snapshot & Double Or Triple Profits - earlytimes.in
Indivior stock hits all-time high at 37.72 USD - Investing.com
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge - sharewise.com
What analysts say about Indivior PLC stockResistance Zone Identification & Big Gains Low Cost - earlytimes.in
Is Indivior PLC stock a dividend growth opportunity2025 Analyst Calls & Verified Entry Point Detection - Newser
Indivior PLC Stock Analysis and ForecastTrading Volume Surges & Low Risk Trading Ideas - earlytimes.in
Indivior Shares Move Above Key Trend Level - Kalkine Media
How Indivior PLC stock reacts to inflationary pressuresQuarterly Trade Review & Growth Focused Entry Reports - Newser
Can Indivior PLC stock weather global recessionJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - Newser
Is Indivior PLC (2IVB) stock attractive post correctionJuly 2025 News Drivers & Real-Time Buy Signal Alerts - Newser
Can Indivior PLC stock sustain institutional interest2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Indivior (INDV) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Indivior PLC a good long term investmentMarket Sentiment Indicators & Rapid Wealth Accumulation - earlytimes.in
Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation (PR Newswire) - Aktiellt
Clinical Evidence Supports Rapid SUBLOCADE® Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment (PR Newswire) - Aktiellt
Indivior PLC (INDV) Stock Price Today | Live Chart & News - Traders Union
Indivior stock hits all-time high of 33.72 USD By Investing.com - Investing.com Australia
Indivior stock hits all-time high of 33.72 USD - Investing.com
Piper Sandler Healthcare Conference - MarketScreener
INDVIndivior Latest Stock News & Market Updates - Stock Titan
Rodman & Renshaw sets $16 target on Indivior stock with Buy rating - MSN
Indivior PLC (INDV) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
Indivior PLC (INDV) Stock Price Prediction for 2026, 2030-2040 - Traders Union
Indivior resolving legacy DOJ matter removes ‘major overhang,’ says Northland - MSN
Indivior price target raised to $41 from $27 at Piper Sandler - MSN
Indivior (INDV) Resolves Major Legal Issue, Outlook Remains Posi - GuruFocus
Indivior Concludes Legacy U.S. Department of Justice Matter - The Malaysian Reserve
Indivior Concludes DOJ Settlement with Final Payment - The Globe and Mail
Indivior pays $295 million to conclude legacy DOJ matter By Investing.com - Investing.com India
Can Indivior PLC (2IVB) stock sustain double digit ROEAnalyst Upgrade & Capital Efficient Trading Techniques - newser.com
Indivior (INDV) Is Up 6.5% After Settling DOJ Liability and Ending Resolution Agreement – Has The Bull Case Changed? - simplywall.st
How Indivior PLC stock valuations compare to rivalsNew Guidance & Accurate Buy Signal Notifications - newser.com
A Fresh Look at Indivior (INDV) Valuation Following Recent Share Price Surge - Yahoo Finance
Indivior Plc Azioni (INDV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.70%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):